Loading candles…
Solara Active Pharma Sciences Ltd emerged as a pure-play active pharmaceutical ingredients (API) company following its formation through the demerger of the API business from Strides Shasun Ltd (now Stride Pharma Sciences) and subsequent acquisition of the human API business from Sequent Scientific Ltd. The company is engaged in manufacturing, production, processing, formulating, sale, import, export, merchandising, distribution, and trading of APIs, alongside providing contract research and manufacturing services (CRAMS). It operates six manufacturing facilities and one research and development center, supporting a portfolio exceeding 60 commercial API products. Solara serves customers across more than 70 countries and focuses on high-value commercial APIs and profitable, high-margin business segments. Notably, it has undertaken recovery and reset activities following a fire incident at its Puducherry facility during the fiscal year 2024-25.
This page is a live market overview for SOLARA ACTIVE PHA SCI LTD (SOLARA) on the NSE. As a listed security, SOLARA ACTIVE PHA SCI LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for SOLARA before placing trades on tick2trade.
As of the latest feed, SOLARA last traded at ₹502.6 on NSE, down ₹8.5 (1.66%) from the previous close of ₹511.1. Today's session range is ₹497.6 – ₹514.3, against a 52-week band of ₹422 – ₹712. Traded volume today stands at 1.50L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for SOLARA in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether SOLARA is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for SOLARA ACTIVE PHA SCI LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in SOLARA. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated SOLARA option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Unaudited Results - Q1-FY26 | To consider and approve the unaudited Standalone and Consolidated financial results for the quarter ended June 30, 2026 | 23 Jul 2026 |
| Audited Results - Q4 & FY26 | Solara Active Pharma Sciences Limited has informed the exchange that the meeting of the Board of Directors of the Company is scheduled to be held on May 15, … | 15 May 2026 |
| Results - Q3-FY25 | To consider and approve the Standalone and Consolidated financial results for the quarter ended December 31, 2025 | 6 Feb 2026 |
| Unaudited Results - Q2 & FY25 | Solara Active Pharma Sciences Limited has informed the Exchange about the Board Meeting to be held on November 05, 2025 to inter-alia consider and approve th… | 5 Nov 2025 |
| Unaudited Results - Q1-FY25 | To consider and approve unaudited standalone and consolidated Financial Results for the quarter ended June 30, 2025 | 25 Jul 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 | 15 May 2025 |
| Other | Solara Active Pharma Sciences Ltd has informed exchange that the meeting of the Rights Issue Committee members of Board of Directors of the Company is schedu… | 2 Apr 2025 |
| Other | To consider and approve the proposal of making First Call on 1,19,98,755 partly paid-up Equity Shares, having a face value of Rs.10/- each (Rs.3.50/- paid-up… | 26 Mar 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.